Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6104-6109
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6104
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6104
Table 1 Patients’ characteristics according to treatment
| TACE | TACE-PEI | |
| Patients (n) | 25 | 27 |
| ean age yr (range) | 63.6 (48-79) | 64 (47-76) |
| M:F (%) | 84:16 | 74.1:25.9 |
| Cirrhosis/no cirrhosis | 22/3 | 23/4 |
| Etiology of cirrhosis (n/%) | ||
| Alcohol | 12 (55) | 13 (57) |
| Hepatitis B or C | 7 (32) | 7 (30) |
| Hemochromatosis | 2 (9) | 1 (4) |
| Unknown | 1 (4) | 2 (9) |
| Liver function (n/%) | ||
| Child Pugh A | 22 (88) | 17 (63) |
| Child Pugh B | 3 (12) | 10 (37) |
| Child Pugh C | 0 | 0 |
| Tumor stage (n) | ||
| Okuda I | 19 | 17 |
| Okuda II | 6 | 9 |
| Okuda III | 0 | 1 |
| AFP | ||
| <100 ng/mL | 14 | 15 |
| ≥100 ng/mL | 11 | 12 |
| Portal vein thrombosis (partial or complete) | 8 | 6 |
| Number of tumor lesions | ||
| 1 | 9 | 13 |
| 2 | 6 | 5 |
| 3 | 5 | 2 |
| >3 | 4 | 5 |
| Diffuse | 0 | 2 |
| Not documented | 1 | 0 |
| Largest diameter >5 cm (US) | 17 | 17 |
- Citation: Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6104-6109
- URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6104